Brenton Rose

Brenton Rose is an Associate Professor of Clinical in the Department of Radiation Medicine and Applied Science at the University of California San Diego (UCSD) School of Medicine. His work focuses on cancer outcomes research, particularly in genitourinary malignancies with an emphasis on prostate and testicular cancers within the Veterans Affairs healthcare system.

Dr. Rose's research interests span several key areas in oncology:

• Racial and ethnic disparities in cancer outcomes and healthcare access
• Prostate cancer screening, risk stratification, and precision medicine
• Long-term complications and survivorship issues in testicular cancer patients
• Genetic and genomic aspects of prostate cancer
• Health services research in Veterans Affairs cancer care
• Optimal treatment strategies for genitourinary cancers

His recent publications demonstrate a strong focus on health disparities, particularly examining differences in cancer outcomes among racial and ethnic groups. Dr. Rose has contributed significantly to understanding how social determinants of health impact cancer care delivery and outcomes, especially within the Veterans Health Administration system. His work often employs large datasets from the Million Veteran Program to investigate genetic and environmental factors influencing prostate cancer risk and outcomes.

Dr. Rose has been actively involved in numerous studies examining the long-term effects of cancer treatments, particularly androgen deprivation therapy, on survivorship issues including metabolic syndrome, osteoporosis, and sexual health among testicular cancer survivors. His research also extends to kidney cancer outcomes and management strategies.

His scientific contributions include important findings on prostate cancer screening guidelines, polygenic risk scores, and treatment outcomes across diverse populations. Dr. Rose's work has implications for improving cancer care delivery and outcomes, particularly for underserved populations.